Welcome to LookChem.com Sign In|Join Free

CAS

  • or

23745-85-9

Post Buying Request

23745-85-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

23745-85-9 Usage

Description

3-O-ALPHA-D-MANNOPYRANOSYL-D-MANNOPYRANOSE is a complex carbohydrate molecule that plays a significant role in various biological processes. It is characterized by its unique structure, which consists of two mannopyranose units connected through a glycosidic linkage. This molecule is known for its potential applications in the fields of biology and medicine due to its ability to interact with specific proteins and other biomolecules.

Uses

Used in Pharmaceutical Industry:
3-O-ALPHA-D-MANNOPYRANOSYL-D-MANNOPYRANOSE is used as a therapeutic agent for targeting specific diseases. Its ability to act as an inhibitor of fibril lectins from enterobacteria makes it a potential candidate for the development of new drugs to combat bacterial infections.
Used in Biotechnology Industry:
In the biotechnology industry, 3-O-ALPHA-D-MANNOPYRANOSYL-D-MANNOPYRANOSE is used as a key component in the study of the cell wall of yeast. It is believed to be the major antigenic determinant, which means it plays a crucial role in the immune response against yeast infections. This molecule can be utilized in the development of vaccines or diagnostic tools for yeast-related diseases.
Used in Research and Development:
3-O-ALPHA-D-MANNOPYRANOSYL-D-MANNOPYRANOSE is also used as a research tool in the field of glycobiology. Its unique structure and functional properties make it an interesting subject for studying the interactions between carbohydrates and proteins, which can lead to a better understanding of various biological processes and the development of new therapeutic strategies.

Check Digit Verification of cas no

The CAS Registry Mumber 23745-85-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,7,4 and 5 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 23745-85:
(7*2)+(6*3)+(5*7)+(4*4)+(3*5)+(2*8)+(1*5)=119
119 % 10 = 9
So 23745-85-9 is a valid CAS Registry Number.
InChI:InChI=1/C12H22O11/c13-1-3-5(15)7(17)8(18)12(22-3)23-10-6(16)4(2-14)21-11(20)9(10)19/h3-20H,1-2H2/t3-,4-,5-,6-,7+,8+,9+,10+,11?,12-/m1/s1

23745-85-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-O-(a-D-Mannopyranosyl)-D-mannopyranose

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:23745-85-9 SDS

23745-85-9Relevant articles and documents

Orthogonal Active-Site Labels for Mixed-Linkage endo-β-Glucanases

Jain, Namrata,Tamura, Kazune,Déjean, Guillaume,Van Petegem, Filip,Brumer, Harry

, p. 1968 - 1984 (2021/05/26)

Small molecule irreversible inhibitors are valuable tools for determining catalytically important active-site residues and revealing key details of the specificity, structure, and function of glycoside hydrolases (GHs). β-glucans that contain backbone β(1,3) linkages are widespread in nature, e.g., mixed-linkage β(1,3)/β(1,4)-glucans in the cell walls of higher plants and β(1,3)glucans in yeasts and algae. Commensurate with this ubiquity, a large diversity of mixed-linkage endoglucanases (MLGases, EC 3.2.1.73) and endo-β(1,3)-glucanases (laminarinases, EC 3.2.1.39 and EC 3.2.1.6) have evolved to specifically hydrolyze these polysaccharides, respectively, in environmental niches including the human gut. To facilitate biochemical and structural analysis of these GHs, with a focus on MLGases, we present here the facile chemo-enzymatic synthesis of a library of active-site-directed enzyme inhibitors based on mixed-linkage oligosaccharide scaffolds and N-bromoacetylglycosylamine or 2-fluoro-2-deoxyglycoside warheads. The effectiveness and irreversibility of these inhibitors were tested with exemplar MLGases and an endo-β(1,3)-glucanase. Notably, determination of inhibitor-bound crystal structures of a human-gut microbial MLGase from Glycoside Hydrolase Family 16 revealed.

A novel two-step synthesis of α-linked mannobioses based on an acid-assisted reverse hydrolysis reaction

Ajisaka, Katsumi,Yagura, Misato,Miyazaki, Tatsuo

experimental part, p. 147 - 150 (2012/03/10)

Instead of an enzyme-assisted reverse hydrolysis reaction for the synthesis of manno-oligosaccharides, we propose here a versatile new approach. By Fischer type glycosylation, a d-mannose solution of extremely high concentration (approximately 83% (w/w)) was incubated at 60 °C for 65 h in 0.5 M HCl. After dilution and neutralization, the small amount of formed β-linked oligosaccharides was hydrolyzed by β-mannosidase. The yields of α-d-Manp-(1→2)-d-Manp (7.9%), α-d-Manp-(1→3)-d-Manp (7.9%), and α-d-Manp-(1→6)-d-Manp (29.1%) isolated by an activated carbon column chromatography were almost identical to those of the enzymatic reaction, but the yield of α-d-Manp-(1→3)-d-Manp increased enormously by the present method.

Production of galacto-oligosaccharides by the β-galactosidase from kluyveromyces lactis: Comparative analysis of permeabilized cells versus soluble enzyme

Rodriguez-Colinas, Barbara,De Abreu, Miguel A.,Fernandez-Arrojo, Lucia,De Beer, Roseri,Poveda, Ana,Jimenez-Barbero, Jesus,Haltrich, Dietmar,Ballesteros Olmo, Antonio O.,Fernandez-Lobato, Maria,Plou, Francisco J.

experimental part, p. 10477 - 10484 (2012/07/17)

The transgalactosylation activity of Kluyveromyces lactis cells was studied in detail. Cells were permeabilized with ethanol and further lyophilized to facilitate the transit of substrates and products. The resulting biocatalyst was assayed for the synthesis of galacto-oligosaccharides (GOS) and compared with two soluble β-galactosidases from K. lactis (Lactozym 3000 L HP G and Maxilact LGX 5000). Using 400 g/L lactose, the maximum GOS yield, measured by HPAEC-PAD analysis, was 177 g/L (44% w/w of total carbohydrates). The major products synthesized were the disaccharides 6-galactobiose [Gal-β(1?6)-Gal] and allolactose [Gal-β(1?6)-Glc], as well as the trisaccharide 6-galactosyl-lactose [Gal-β(1?6)-Gal-β(1?4)-Glc], which was characterized by MS and 2D NMR. Structural characterization of another synthesized disaccharide, Gal-β(1?3)-Glc, was carried out. GOS yield obtained with soluble β-galactosidases was slightly lower (160 g/L for Lactozym 3000 L HP G and 154 g/L for Maxilact LGX 5000); however, the typical profile ith a maximum GOS concentration followed by partial hydrolysis of the newly formed oligosaccharides was not observed with the soluble enzymes. Results were correlated with the higher stability of β-galactosidase when permeabilized whole cells were used.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 23745-85-9